Clinical, Molecular and Physiopathological Study of Cohen Syndrome and Cohen-like Syndromes

计划入组 100 人 · 首次发布于 2013 年 7 月 25 日

Lynne Cohen Consortium Project: Multi-Center Database/Registry

计划入组 176 人 · 首次发布于 2008 年 10 月 22 日

Capital Mãe

计划入组 446 人

Orphanin antagonists (The GI company)

PAD4 inhibitors(Capital Medical University)

IGC-AD1

EZRA COHEN

Israel

Cohen & Steers

United States

Cohen Global Ltd.

Bleichroeder Acquisition Corp. II Completes $287.5M IPO Targeting Healthcare Technology Disruption

Summit Therapeutics Completes Enrollment in Phase III HARMONi Trial and Receives FDA Fast Track Designation for Ivonescimab

Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment